Related references
Note: Only part of the references are listed.The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma A meta-analysis
Min Zhou et al.
MEDICINE (2019)
Pseudomonas Exotoxin Immunotoxins and Anti-Tumor Immunity: From Observations at the Patient's Bedside to Evaluation in Preclinical Models
Yasmin Leshem et al.
TOXINS (2019)
Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials
Benjamin M. Ellingson et al.
NEUROTHERAPEUTICS (2017)
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada et al.
LANCET ONCOLOGY (2015)
Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence
Alexander Radbruch et al.
NEURO-ONCOLOGY (2015)
Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry
Anh N. Tran et al.
NEURO-ONCOLOGY (2014)
Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
Tracy T. Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Standards of care for treatment of recurrent glioblastoma-are we there yet?
Michael Weller et al.
NEURO-ONCOLOGY (2013)
BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
Thomas Reithmeier et al.
BMC CANCER (2010)
Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas
Casilda Balmaceda et al.
CANCER (2008)
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma
Antje Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Long term survival in a patient with recurrent malignant glioma treated with intratumoral infusion of an IL4-targeted toxin (NBI-3001)
NG Rainov et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
How effective is BCNU in recurrent glioblastoma in the modern era?: A phase II trial
AA Brandes et al.
NEUROLOGY (2004)
Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity
JE Wedekind et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Share Paper
